Related Experiment Video
Updated: May 10, 2025

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation-Ubiquitylation
Lingkai Gu1, Zhangjin Shen2, Shizhen Shen3
1Zhejiang Key Laboratory of Maternal and Infant Health, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Abstract:
Ovarian cancer is an aggressive gynecological tumor usually diagnosed with widespread metastases. Extracellular vesicles (EVs), though recognized as important mediators of tumor metastasis, have received limited attention into their specific functions via the mRNA profiling. Here it is reported elevated expression and selective enrichment of INAVA mRNA in both plasma- and tissue-derived EVs from ovarian cancer patients, which is positively correlated with distant metastasis and poor prognosis. Functionally, INAVA mRNA, upon uptake and translation, activates normal ovarian fibroblasts (NOFs) and drives extensive peritoneum metastasis in the orthotopic xenograft mouse model. Mechanistically, INAVA competitively binds with high mobility group protein A2 (HMGA2) and consequently inhibit its interaction with vaccinia-related kinase 1 (VRK1), leading to reduced HMGA2 phosphorylation on Ser105. Interestingly, this inhibitory phosphorylation stabilizes HMGA2 via blocking tripartite motif-containing 21 (TRIM21) -mediated K48-linked ubiquitylation, and ultimately enhances the transcription of STAT3 to activate NOFs. Lastly, a cell-permeable peptide that disrupts the INAVA-HMGA2 interaction leads to attenuated NOF activation and provides a promising strategy for ovarian cancer therapy.
Insights
INAVA mRNA in extracellular vesicles promotes ovarian cancer metastasis by activating fibroblasts. Disrupting this interaction offers a potential therapeutic strategy for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Ovarian cancer is frequently diagnosed at advanced stages with metastasis.
- Extracellular vesicles (EVs) are implicated in tumor metastasis, but their specific mRNA functions are underexplored.
- INAVA mRNA's role in ovarian cancer progression requires further investigation.
Purpose of the Study:
- To investigate the function of INAVA mRNA within extracellular vesicles in ovarian cancer metastasis.
- To elucidate the molecular mechanism by which INAVA mRNA promotes ovarian cancer progression.
- To explore therapeutic strategies targeting the INAVA-mediated pathway.
Main Methods:
- Analysis of INAVA mRNA expression in plasma- and tissue-derived EVs from ovarian cancer patients.
- Functional studies using orthotopic xenograft mouse models to assess metastasis.
- Investigation of molecular interactions involving INAVA, HMGA2, VRK1, TRIM21, and STAT3.
- Development and testing of a cell-permeable peptide to disrupt INAVA-HMGA2 interaction.
Main Results:
- Elevated INAVA mRNA expression in EVs from ovarian cancer patients correlates with distant metastasis and poor prognosis.
- Uptake and translation of INAVA mRNA activate normal ovarian fibroblasts (NOFs), driving peritoneal metastasis.
- INAVA inhibits HMGA2 phosphorylation by VRK1, preventing TRIM21-mediated degradation and enhancing STAT3 transcription.
- A peptide disrupting the INAVA-HMGA2 interaction attenuates NOF activation.
Conclusions:
- INAVA mRNA in EVs is a key driver of ovarian cancer metastasis by activating fibroblasts through a novel molecular pathway.
- Targeting the INAVA-HMGA2 interaction presents a promising therapeutic avenue for ovarian cancer treatment.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
The Nucleolus

